外科瘤学多学科团队会议有什么不同?
Eden A Smith1, Jesse D Ey1, Vishak Senthil1
1Department of Surgery, The University of Adelaide, The Queen Elizabeth Hospital, Woodville, Australia.
Annals of surgical oncology
|November 16, 2024
概括
多学科团队 (MDT) 会议对近一半的外科瘤患者的治疗有显著的改变. 虽然建议经常被执行,但可预测性主要受到女性性别的影响,很少有其他患者因素影响结果.
科学领域:
- 手术瘤学手术瘤学
- 医疗保健服务研究 医疗服务研究
- 临床决策 - 临床决策
背景情况:
- 多学科团队 (MDT) 会议在手术和瘤护理中至关重要,但资源密集.
- 评估MDT会议的有效性对于优化资源配置和患者结果至关重要.
研究的目的:
- 评估手术瘤学中MDT建议的可预测性.
- 确定患者管理计划在多大程度上改变了MDT后的讨论.
- 确定MDT建议的实施率.
主要方法:
- 一项队列研究对上部胃肠道和结肠直肠外科的MDT会议进行了审计.
- 在MDT前的管理计划与正式的一致性和变化建议进行了比较.
- 在8个月后审查了患者记录,以评估建议的实施情况.
主要成果:
- 在438个案例中,72.37%的MDT建议被正确预测.
- 在讨论的近一半患者中,管理计划发生了变化.
- 在89.62%的案例中,正式的MDT建议被执行.
- 女性患者的可预测性更高 (P=0.0201),但没有其他患者因素预测可预测性或实施性.
结论:
- 手术MDT会议显著影响患者管理,在近50%的病例中改变计划.
- 建议的执行率很高,但可预测性仅限于特定的患者人口统计学.
- 进一步的研究可能会探索影响MDT推可预测性和实施的因素.
相关概念视频
Methods of Documentation VI: Case Management Model
559
The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic...
For example, a patient with a chronic...
559
Cancer Survival Analysis
328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K


